Embarc
Skip to content
Resources
Operating Companies
Capital Providers
Calendar
Sign in
Skip to content
Open menu
Leadership
Mark Schoenebaum, MD
SPACs
1
Failed
0
Completed
1
$100M
Biopharma
HSAC
Registration
IPO
Definitive Agreement
Completed
Completed
Health Sciences Acquisitions Corporation
Immunovant
IMVT
154%